✦ LIBER ✦

Potential of AAV vectors in the treatment of metabolic disease

✍ Scribed by Alexander, I E; Cunningham, S C; Logan, G J; Christodoulou, J

Book ID: 109855174
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 155 KB
Volume: 15
Category: Article
ISSN: 0969-7128
DOI: 10.1038/gt.2008.64

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of AAV Vectors for the Treatm

Evaluation of AAV Vectors for the Treatment of Hemophilia A and B

✍ McClelland, Alan 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 67 KB

The packaging capacity of adeno-associat

The packaging capacity of adeno-associated virus (AAV) and the potential for wild-type-plus AAV gene therapy vectors

✍ Paul L. Hermonat; J.Gerald Quirk; Brian M. Bishop; Li Han 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 880 KB

Viral vectors in the treatment of Parkin

Viral vectors in the treatment of Parkinson's disease

✍ David S. Latchman; Robert S. Coffin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

s disease is an obvious target for the development of gene therapy procedures which could involve both the delivery of the gene encoding tyrosine hydroxylase to boost dopamine production or the delivery of genes encoding neurotrophic factors such as GDNF to promote the survival of dopaminergic neuro

Vectors for the treatment of autoimmune

Vectors for the treatment of autoimmune disease

✍ Gould, D J; Favorov, P 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 189 KB

Nonviral Vectors for the Treatment of Di

Nonviral Vectors for the Treatment of Disease

✍ Templeton, Nancy Smyth 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 71 KB

Intrathecal administration of AAV vector

Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice

✍ Watson, G; Bastacky, J; Belichenko, P; Buddhikot, M; Jungles, S; Vellard, M; Mob 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 372 KB